↓ Skip to main content

Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
15 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer
Published in
Cochrane database of systematic reviews, July 2012
DOI 10.1002/14651858.cd008941.pub2
Pubmed ID
Authors

Anna Dorothea Wagner, Christoph Thomssen, Johannes Haerting, Susanne Unverzagt, Wagner AD, Thomssen C, Haerting J, Unverzagt S

Abstract

Vascular-endothelial-growth-factor (VEGF) is a key mediator of angiogenesis. VEGF-targeting therapies have shown significant benefits and been successfully integrated in routine clinical practice for other types of cancer, such as metastatic colorectal cancer. By contrast, individual trial results in metastatic breast cancer (MBC) are highly variable and their value is controversial.

Twitter Demographics

The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ecuador 2 2%
Canada 2 2%
Ireland 1 1%
Egypt 1 1%
United Kingdom 1 1%
Unknown 83 92%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 21%
Researcher 19 21%
Student > Bachelor 14 16%
Student > Ph. D. Student 8 9%
Other 7 8%
Other 23 26%
Readers by discipline Count As %
Medicine and Dentistry 47 52%
Agricultural and Biological Sciences 14 16%
Unspecified 8 9%
Nursing and Health Professions 7 8%
Psychology 3 3%
Other 11 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 February 2016.
All research outputs
#1,223,373
of 12,100,779 outputs
Outputs from Cochrane database of systematic reviews
#2,455
of 7,978 outputs
Outputs of similar age
#11,481
of 112,183 outputs
Outputs of similar age from Cochrane database of systematic reviews
#30
of 103 outputs
Altmetric has tracked 12,100,779 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 112,183 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 103 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.